Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection

2016 ◽  
Vol 18 (3) ◽  
pp. 255-263 ◽  
Author(s):  
Z.-M. Li ◽  
Y.-F. Peng ◽  
C.-Z. Du ◽  
J. Gu
Keyword(s):  
Colon Cancer ◽  
Scoring System ◽  
Primary Tumour ◽  
Tumour Resection ◽  
Synchronous Metastases ◽  
Primary Tumour Resection

scholarly journals Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC)

2018 ◽  
Vol 29 ◽  
pp. viii177-viii178
Author(s):  
K.L. van Rooijen ◽  
S.A. Kurk ◽  
D.E.W. van der Kruijssen ◽  
S. Elias ◽  
A.M. May ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Primary Tumour ◽  
Tumour Resection ◽  
Metastatic Colon Cancer ◽  
Primary Tumour Resection

Pitfalls of using denosumab preoperatively to treat refractory severe hypercalcaemia

2020 ◽  
Vol 13 (4) ◽  
pp. e233665 ◽  
Author(s):  
Yulong Li ◽  
Chris Y Fan ◽  
Andrea Manni ◽  
William F Simonds
Keyword(s):  
Primary Tumour ◽  
Tumour Resection ◽  
Debulking Surgery ◽  
Off Label ◽  
Conventional Management ◽  
History Of ◽  
Lung Metastasectomy ◽  
Vitamin D Supplements ◽  
Severe Hypercalcaemia ◽  
Primary Tumour Resection

A 40-year-old man, with a history of metastatic parathyroid carcinoma, status post primary tumour resection and lung metastasectomy, was hospitalised for persistent severe hypercalcaemia and elevated parathyroid hormone levels despite conventional management and escalating doses of cinacalcet. A single dose (120 mg) of denosumab was given and his calcium level plummeted from 14.8 mg/dL to 5.5 mg/dL. After second lung metastasectomy, he developed prolonged hypocalcaemia that required calcium and vitamin D supplements for more than 3 years. In patients with severe hypercalcaemia refractory to conventional therapies, denosumab has been used off-label with some success. A known side effect of denosumab is hypocalcaemia, which is often short-lived. The risk of prolonged hypocalcaemia should be fully evaluated before using denosumab preoperatively, especially in patients with renal insufficiency, prolonged hyperparathyroidism or anticipated tumour debulking surgery.

Nodal Staging in Penile Carcinoma by Dynamic Sentinel Node Biopsy After Previous Therapeutic Primary Tumour Resection

2010 ◽  
Vol 58 (5) ◽  
pp. 748-751 ◽  
Author(s):  
Niels M. Graafland ◽  
Renato A. Valdés Olmos ◽  
Willem Meinhardt ◽  
Axel Bex ◽  
Henk G. van der Poel ◽  
...  
Keyword(s):  
Sentinel Node ◽  
Sentinel Node Biopsy ◽  
Primary Tumour ◽  
Penile Carcinoma ◽  
Tumour Resection ◽  
Nodal Staging ◽  
Node Biopsy ◽  
Dynamic Sentinel Node Biopsy ◽  
Primary Tumour Resection
Sign in / Sign up

Export Citation Format

Share Document